Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 3, 2009, Pages 427-428

  Rodríguez Blanco, María ^a   Marticorena, Joaquin ^b   Gómez Ulla, Francisco ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Instituto Tecnologico de Oftalmologia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

AGED; CASE REPORT; DIALYSIS; DISEASE COURSE; DRUG EFFICACY; EYE EXAMINATION; FEMALE; HUMAN; LETTER; OPTICAL COHERENCE TOMOGRAPHY; PHACOEMULSIFICATION; PRIORITY JOURNAL; PSEUDOPHAKIA; PSEUDOPHAKIC CYSTOID MACULAR EDEMA; RETINA FOVEA; RETINA FOVEA THICKNESS; RETINA MACULA CYSTOID EDEMA; TREATMENT FAILURE; VISUAL ACUITY; ZONULAR DIALYSIS;

AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA; PHACOEMULSIFICATION; PSEUDOPHAKIA; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 59749091764     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0897-1     Document Type: Letter

References (8)

1. Arevalo JF, Garcia-Amaris RA, Roca JA, Sanchez JG, Wu L, Berrocal MH, Pan-American Collaborative Retina Study Group et al (2007) Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: Pilot study of the Pan-American Collaborative Retina Study Group. J Cataract Refract Surg 33:2098-2105, doi: 10.1016/ j.jcrs.2007.07.046
2. Diaz-Llopis M, Amselem L, Cervera E, Garcia-Depech S, Torralba C, Montero J (2007) Intravitreal injection of bevacizumab for pseudophakic cystoid macular edema resistant to steroids. Arch Soc Esp Oftalmol 82:447-450
3. Flach AJ (1998) The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 96:557-634
4. Herschler J (1976) Increased intraocular pressure induced by repository corticosteroids. Am J Ophthalmol 82:90-93
5. Mason JO, Albert MA, Vail R (2006) Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina 26:356-357, doi: 10.1097/00006982-200603000-00018
6. Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA (2007) Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 27:426-431, doi: 10.1097/ IAE.0b013e31804a7af2
7. Rosenfeld PJ, Moshfeghi AA, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36:331-335
8. Spitzer MS, Ziemssen F, Yoeruek E, Petermeir K, Aisenbrey S, Szurman P (2008) Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg 34:70-75, doi: 10.1016/j.jcrs.2007.08.021